Keyphrases
Israel
100%
Extended-spectrum-lactamase
57%
Bloodstream Infection
57%
Enterobacteriaceae
56%
Israeli
50%
Carbapenem-resistant Enterobacteriaceae
40%
Escherichia Coli
34%
Klebsiella Pneumoniae Carbapenemase
29%
Klebsiella Pneumoniae (K. pneumoniae)
27%
Carbapenemase-producing Enterobacterales
25%
Methicillin-resistant Staphylococcus Aureus
24%
KPC-2
23%
Antimicrobial Resistance
22%
Infection Control
21%
ESBL-producing Enterobacteriaceae
21%
Bacteremia
21%
Acute Hospital
20%
Confidence Interval
20%
National Survey
20%
Healthcare Workers
19%
Odds Ratio
17%
Risk Factors
16%
COVID-19
16%
Plasmid
16%
Post-acute Care
15%
Empirical Therapy
15%
Carbapenem Resistance
14%
Carbapenems
14%
Long-term Care Facilities
14%
National Policy
13%
Enterobacter
13%
OXA-48
12%
Pseudomonas Aeruginosa (P. aeruginosa)
12%
Carbapenem-resistant Acinetobacter Baumannii
11%
United States
11%
Carbapenemase
11%
Producing Escherichia Coli
11%
Infection Rate
10%
Epidemiology
10%
Hospital Admission
10%
30-day Mortality
10%
Retrospective Cohort Study
10%
Rehabilitation Centers
10%
Neonatal Intensive Care Unit
10%
Tel Aviv
10%
Infection Prevention
9%
Cephalosporin Resistance
9%
ESBL-E
9%
Antibiotics
8%
Patient Outcomes
8%
Medicine and Dentistry
Enterobacteriaceae
44%
Penicillinase
44%
Carbapenem-Resistant Enterobacteriaceae
33%
Bloodstream Infection
29%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
27%
Extended Spectrum Beta Lactamase
26%
Infection
25%
Antibiotic Resistance
22%
Antibiotics
20%
Antiinfective Agent
17%
Prevalence
15%
Infection Control
15%
Klebsiella pneumoniae
14%
Carbapenem
14%
Bacteremia
13%
Odds Ratio
13%
Long-Term Care
12%
COVID-19
12%
Carbapenem Derivative
12%
Pathogen
11%
Rehabilitation Center
10%
Public Health
10%
Subacute Care
9%
Escherichia coli
9%
Acinetobacter Baumannii
8%
Infection Prevention
8%
Cohort Analysis
7%
Catheter Infection
7%
Enterobacter
7%
Cohort Effect
7%
Quinolone Derivative
7%
Blood Culture
6%
Methicillin Resistant Staphylococcus Aureus
6%
Carbapenemase Producing Enterobacteriaceae
6%
Streptococcus Pneumoniae
6%
Lactam
6%
Intensive Care Unit
6%
Cephalosporin
6%
Sepsis
6%
Emergency Care
5%
Targeted Therapy
5%
Clostridium Difficile Infection
5%